Literature DB >> 1858770

On the temporal development of erythrocyte sedimentation rate using sealed vacuum tubes.

A Kallner1.   

Abstract

The temporal development of the erythrocyte sedimentation rate (ESR) was studied in wide, short vacuum tubes. It was found that in about 3% of the specimens arriving in the laboratory the ESR developed in three different phases during 60 min, whereas the other showed only two. The specimens with three phases behaved similarly in the Westergren method. It was shown that the Westergren ESR can be estimated with an acceptable accuracy already from measurements obtained after 30 min. Reproducibility and precision were improved by using a special instrument. Several advantages by this procedure were recognized, e.g., quicker results, identification of several otherwise missed rapid ESR. Accurate timing of the readings further improves accuracy and precision, and permits estimation of ESR (Westergren) up to 100 mm. In view of the obvious phases in the development of the ESR, it is proposed that this abbreviation is interpreted as erythrocyte sedimentation reaction and that the kind of quantity that is length is expressed in mm.

Mesh:

Year:  1991        PMID: 1858770     DOI: 10.1002/ajh.2830370310

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Three-way comparison of methods for the measurement of the erythrocyte sedimentation rate.

Authors:  Johnny Ndoni Mahlangu; Melony Davids
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

2.  A Comparison Between the StaRRsed Auto-Compact Erythrocyte Sedimentation Rate Instrument and the Westergren Method.

Authors:  Juha Horsti; Riikka Rontu; Auni Collings
Journal:  J Clin Med Res       Date:  2010-12-11

3.  Comparison of the erythrocyte sedimentation rate measured by the Micro Test 1 sedimentation analyzer and the conventional Westergren method.

Authors:  Serap Arikan; Nalan Akalin
Journal:  Ann Saudi Med       Date:  2007 Sep-Oct       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.